Phase II  study of bemnifosbuvir in high-risk participants in a hospital setting with moderate COVID-19

Future Virology, Ahead of Print.
Source: Future Virology - Category: Virology Authors: Source Type: research
More News: COVID-19 | Hospitals | Study | Virology